These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15661554)

  • 21. Health-related quality-of-life studies of the National Cancer Institute of Canada Clinical Trials Group.
    Osoba D; Dancey J; Zee B; Myles J; Pater J
    J Natl Cancer Inst Monogr; 1996; (20):107-11. PubMed ID: 8750480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health-related quality of life measurement in symptom management trials.
    Ganz PA; Goodwin PJ
    J Natl Cancer Inst Monogr; 2007; (37):47-52. PubMed ID: 17951231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.
    Martinelli F; Quinten C; Maringwa JT; Coens C; Vercauteren J; Cleeland CS; Flechtner H; Gotay C; Greimel E; King M; Mendoza T; Osoba D; Reeve BB; Ringash J; Koch JS; Shi Q; Taphoorn MJ; Weis J; Bottomley A;
    Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):587-99. PubMed ID: 21958103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges and recommendations for advancing the state-of-the-science of quality of life assessment in symptom management trials.
    Buchanan DR; O'Mara AM; Kelaghan JW; Sgambati M; McCaskill-Stevens W; Minasian L
    Cancer; 2007 Oct; 110(7):1621-8. PubMed ID: 17868120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing cancer-related quality of life across a spectrum of applications.
    Gotay CC
    J Natl Cancer Inst Monogr; 2004; (33):126-33. PubMed ID: 15504923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of health-related quality of life in prescribing research. Part 2: methodological considerations for the assessment of health-related quality of life in clinical trials.
    Calvert MJ; Freemantle N
    J Clin Pharm Ther; 2004 Feb; 29(1):85-94. PubMed ID: 14748903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials.
    Nayfield SG; Ganz PA; Moinpour CM; Cella DF; Hailey BJ
    Qual Life Res; 1992 Jun; 1(3):203-10. PubMed ID: 1363776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health-related quality of life as an endpoint in oncology phase I trials: a systematic review.
    Fiteni F; Ray IL; Ousmen A; Isambert N; Anota A; Bonnetain F
    BMC Cancer; 2019 Apr; 19(1):361. PubMed ID: 30991990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ambulatory cancer and US general population reference values and cutoff scores for the functional assessment of cancer therapy.
    Pearman T; Yanez B; Peipert J; Wortman K; Beaumont J; Cella D
    Cancer; 2014 Sep; 120(18):2902-9. PubMed ID: 24853866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.
    Quinten C; Coens C; Mauer M; Comte S; Sprangers MA; Cleeland C; Osoba D; Bjordal K; Bottomley A;
    Lancet Oncol; 2009 Sep; 10(9):865-71. PubMed ID: 19695956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of the quality of statistical methods employed for analysing quality of life data in cancer randomised controlled trials.
    Hamel JF; Saulnier P; Pe M; Zikos E; Musoro J; Coens C; Bottomley A
    Eur J Cancer; 2017 Sep; 83():166-176. PubMed ID: 28738257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-related quality of life in patients undergoing drug therapy for advanced non-small-cell lung cancer.
    Fallowfield LJ; Harper P
    Lung Cancer; 2005 Jun; 48(3):365-77. PubMed ID: 15893006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using factor analysis to confirm the validity of children's self-reported health-related quality of life across different modes of administration.
    Varni JW; Limbers CA; Newman DA
    Clin Trials; 2009 Apr; 6(2):185-95. PubMed ID: 19342471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health-related quality of life and enrollment in phase 1 trials in children with incurable cancer.
    Barrera M; D'Agostino N; Gammon J; Spencer L; Baruchel S
    Palliat Support Care; 2005 Sep; 3(3):191-6. PubMed ID: 16594458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Other paradigms: health-related quality of life as a measure in cancer treatment: its importance and relevance.
    Trask PC; Hsu MA; McQuellon R
    Cancer J; 2009; 15(5):435-40. PubMed ID: 19826365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience.
    Bottomley A; Aaronson NK;
    J Clin Oncol; 2007 Nov; 25(32):5082-6. PubMed ID: 17991925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review.
    Fiteni F; Anota A; Westeel V; Bonnetain F
    BMC Cancer; 2016 Feb; 16():122. PubMed ID: 26892541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery.
    Quinten C; Kenis C; Decoster L; Debruyne PR; De Groof I; Focan C; Cornelis F; Verschaeve V; Bachmann C; Bron D; Luce S; Debugne G; Van den Bulck H; Goeminne JC; Baitar A; Geboers K; Petit B; Langenaeken C; Van Rijswijk R; Specenier P; Jerusalem G; Praet JP; Vandenborre K; Lycke M; Flamaing J; Milisen K; Lobelle JP; Wildiers H
    Qual Life Res; 2019 Mar; 28(3):663-676. PubMed ID: 30511255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measuring health-related quality of life in clinical trials in cystic fibrosis.
    Abbott J; Hart A; Havermans T; Matossian A; Goldbeck L; Barreto C; Bergsten-Brucefors A; Besier T; Catastini P; Lupi F; Staab D
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S82-5. PubMed ID: 21658648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.